SCHEMBL5221241

SCHEMBL5221241

CCNc1cc(C(=O)O)c(F)c(N2CCCC2=O)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 12/20 0.51
CYP1A2 P05177 2/20 0.51
CYP3A4 P08684 2/20 0.51
CYP2D6 P10635 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
CTSD P07339 11/20 0.40
BACE2 Q9Y5Z0 11/20 0.40
ALDH1A1 P00352 4/20 0.39
HPGD P15428 1/20 0.39
GAA P10253 1/20 0.38
HSD17B10 Q99714 2/20 0.37
TP53 P04637 2/20 0.37
PKM P14618 2/20 0.37
MAPK1 P28482 1/20 0.37
NPC1 O15118 1/20 0.36
GLA P06280 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5216498 0.90 BACE1 (0.47) BACE1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5221777 0.81 ALDH1A1 (0.40) BACE1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5853388 0.78 ALDH1A1 (0.53) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5223182 0.76 BACE1 (0.40) BACE1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5223174 0.76 BACE1 (0.49) BACE1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5221708 0.76 BACE1 (0.75) BACE1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5221698 0.76 BACE1 (0.75) BACE1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5219440 0.76 CTSD (0.58) BACE1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5220634 0.75 BACE1 (0.52) BACE1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5220629 0.75 BACE1 (0.43) BACE1CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed